These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23304907)

  • 1. Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.
    Wasti SP; Simkhada P; Randall J; Freeman JV; van Teijlingen E
    J Health Popul Nutr; 2012 Dec; 30(4):410-9. PubMed ID: 23304907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study.
    Shrestha A; Poudel L; Shrestha S; Jha N; Kuikel BS; Shakya P; Kunwar RS; Pandey LR; Kc MB; Wilson EC; Deuba K
    BMC Health Serv Res; 2024 Aug; 24(1):927. PubMed ID: 39138448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study.
    Wasti SP; Simkhada P; Randall J; Freeman JV; van Teijlingen E
    PLoS One; 2012; 7(5):e35547. PubMed ID: 22563464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.
    Bezabhe WM; Chalmers L; Bereznicki LR; Peterson GM; Bimirew MA; Kassie DM
    PLoS One; 2014; 9(5):e97353. PubMed ID: 24828585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators for adherence to antiretroviral therapy, and strategies to address the barriers in key populations, Mumbai-A qualitative study.
    Acharya S; Parthasarathy MR; Karanjkar V; Katkar S; Setia MS
    PLoS One; 2024; 19(7):e0305390. PubMed ID: 38990894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "What if I got rejected by the girl? I would rather stop the pills": barriers and facilitators of adherence to antiretroviral therapy for emerging adults aged 18-29 living with HIV in Zimbabwe.
    Jopling R; Mutsvuke W; Fertig M; O'Cleirigh C; Mangezi W; Abas M
    AIDS Care; 2024 Jul; 36(sup1):168-178. PubMed ID: 38537178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
    Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
    AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.
    Loeliger KB; Niccolai LM; Mtungwa LN; Moll A; Shenoi SV
    AIDS Care; 2016 Aug; 28(8):982-93. PubMed ID: 27043077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.
    Krummenacher I; Spencer B; Du Pasquier S; Bugnon O; Cavassini M; Schneider MP
    Int J Clin Pharm; 2014 Aug; 36(4):716-24. PubMed ID: 24913358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study.
    Kumarasamy N; Safren SA; Raminani SR; Pickard R; James R; Krishnan AK; Solomon S; Mayer KH
    AIDS Patient Care STDS; 2005 Aug; 19(8):526-37. PubMed ID: 16124847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caretakers' barriers to pediatric antiretroviral therapy adherence in Vietnam - A qualitative and quantitative study.
    Tran CT; Pham TH; Tran KT; Nguyen TKC; Larsson M
    Appl Nurs Res; 2017 Jun; 35():1-5. PubMed ID: 28532715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I want to be healthy and move on": A qualitative study of barriers and facilitators to antiretroviral treatment adherence among young adult survivors with perinatal HIV in Thailand.
    Aurpibul L; Tangmunkongvorakul A; Detsakunathiwatchara C; Srita A; Masurin S; Meeart P; Chueakong W
    PLoS One; 2024; 19(7):e0305918. PubMed ID: 39012925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to HIV Treatment Adherence: A Qualitative Study of Discrepancies Between Perceptions of Patients and Health Providers in Tanzania and Uganda.
    Moucheraud C; Stern AF; Ahearn C; Ismail A; Nsubuga-Nyombi T; Ngonyani MM; Mvungi J; Ssensamba J
    AIDS Patient Care STDS; 2019 Sep; 33(9):406-413. PubMed ID: 31517526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting.
    Watt MH; Maman S; Earp JA; Eng E; Setel PW; Golin CE; Jacobson M
    Soc Sci Med; 2009 May; 68(10):1793-800. PubMed ID: 19328609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to and facilitators of adherence to antiretroviral therapy among people living with HIV in Lao PDR: a qualitative study.
    Portelli MS; Tenni B; Kounnavong S; Chanthivilay P
    Asia Pac J Public Health; 2015 Mar; 27(2):NP778-88. PubMed ID: 22535549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study.
    Sanjobo N; Frich JC; Fretheim A
    SAHARA J; 2008 Sep; 5(3):136-43. PubMed ID: 18979047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.
    Iwuji C; Chimukuche RS; Zuma T; Plazy M; Larmarange J; Orne-Gliemann J; Siedner M; Shahmanesh M; Seeley J
    PLoS One; 2020; 15(9):e0239513. PubMed ID: 32970730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.
    Ankomah A; Ganle JK; Lartey MY; Kwara A; Nortey PA; Okyerefo MP; Laar AK
    BMC Infect Dis; 2016 Dec; 16(1):738. PubMed ID: 27927183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.